Lindbrook Capital »

Keros Therapeutics shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.9k 89 66.20
2023-12-31 $3.5k 89 39.76
2023-09-30 $605 19 31.89
2023-06-30 $0 0 0.00
2022-12-31 $1.8k 38 48.03
2022-09-30 $999 17 58.82
2022-06-30 $0 8 0.00
2022-03-31 $999 17 58.82